Intelligence desk 12 languages Signal over noise

Bio Tech Radar

Strategic intelligence for senior leadership at a metabolomics and multiomics service provider, tracking competitive moves, regulatory shifts, and customer demand in US and European biotech markets.

Stay ahead of the competitive metabolomics landscape: track mergers, new platform launches (Bruker timsTOF, Sciex Triple Quad), and shifts in pharma/academic outsourcing trends.

About us

Why this desk matters

Curated relevance

Track competitor moves: monitor Metabolon’s HD4 platform updates, Quest’s test menu expansions, and Eurofins’ acquisition strategy with weekly curated briefings from 200+ industry sources.

Pattern-aware briefings

Regulatory radar: get early alerts on FDA CLIA/CAP policy changes, EMA IVDR implementation timelines, and NIH data-sharing mandates that affect your lab’s compliance and customer contracts.

Cross-language clarity

Customer intelligence: surface unmet needs in microbiome sequencing (16S vs shotgun metagenomics) and multiomics integration by analyzing publications, conference abstracts, and RFPs from big pharma and academic consortia.

Latest Spotlight

Open archive
Microprotein Reproducibility Crisis and Path to Clinical Translation: Integration of Benchmarking, Immunopeptidomics, and Regulatory Hurdles

2026-05-27 09:00 UTC

Microprotein discovery faces a reproducibility crisis with only 3.5% of peptides replicable across studies, yet immunopeptidomics achieves 65% high-confidence detection vs 7.8% for conventional proteomics, necessitating urgent standardization, orthogonal validation via targeted metabolomics, and regulatory clarity before commercial diagnostics can advance.

Want to run a Spotlight on a custom topic?

Run your own

Latest briefing

Open archive
Microbiome breakthroughs: gut metabolites shape immunity and muscle health, while new tools enable decentralized proteomics and viral discovery.

2026-06-03 - 2026-06-09 · 7 days

This week's microbiome research highlights a surge in mechanistic studies linking gut microbial metabolites to host physiology, alongside methodological advances that promise to accelerate discovery. Key findings include the identification of bacterial acetylcholine production from dietary choline, which enhances mucos

  • Commensal gut bacteria produce acetylcholine from dietary choline, enhancing mucosal IgA and resistance to Salmonella infection via nicotinic receptors (S13).
  • Adaptive immune aging in mice reduces gut microbial vitamin B6 biosynthesis and systemic VB6 levels, establishing a causal link between immune aging and microbiome function (S12).

Recent posts

View all